for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

AstraZeneca forecasts 2021 growth, reports Q4 sales beat

Feb 11 (Reuters) - AstraZeneca on Thursday forecast 2021 revenue growth after the COVID-19 vaccine developer beat analyst’s estimates for fourth-quarter product sales, as a wide range of therapies helped cushion the hit from the pandemic. (Reporting by Pushkala Aripaka in Bengaluru and Ludwig Burger in Frankfurt; Editing by Shounak Dasgupta)

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up